Displaying 51 - 60 of 13511
Drupal spam blocked by CleanTalk.
Author year
Blockade of PD-1 Attenuated Post-Sepsis Aspergillosis via The Activation Of IFN-γ and The Dampening of IL-10. Vu CTB, Thammahong A, Yagita H, Azuma M, Hirankarn N, Ritprajak P, Leelahavanichkul A. 2019
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Ghez D, Calleja A, Protin C, Baron M, Ledoux MP, Damaj G, Dupont M, Dreyfus B, Ferrant E, Herbaux C, Laribi K, Le Calloch R, Malphettes M, Paul F, Souchet L, Truchan-Graczyk M, Delavigne K, Dartigeas C, Ysebaert L; French Innovative Leukemia Organization (FILO) CLL group. 2018
Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis Daver N, Kontoyiannis DP. 2017
Interleukin-17 in Antifungal Immunity. Sparber F, Leibund Gut-Landmann S. 2019
Epidemiology and antifungal susceptibility profile of Aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies. Cho SY, Lee DG, Kim WB, Chun HS, Park C, Myong JP, Park YJ, Choi JK, Lee HJ, Kim SH, Park SH, Choi SM, Choi JH, Yoo JH. 2019
Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches. Janbon G, Quintin J, Lanternier F, d'Enfert C. 2019
Non-lipopeptide fungi-derived peptide antibiotics developed since 2000. Zhao P, Xue Y, Li J, Li X, Zu X, Zhao Z, Quan C, Gao W, Feng S. 2019
Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro. Jones CN, Ellett F, Robertson AL, Forrest KM, Judice K, Balkovec JM, Springer M, Markmann JF, Vyas JM, Warren HS, Irimia D. 2019
Onychomycosis with greenish-black discolorations and recurrent onycholysis caused by Candida parapsilosis. Ge G, Yang Z, Li D, Sybren de Hoog G, Shi D. 2019
Copper Homeostasis in Aspergillus fumigatus: Opportunities for Therapeutic Development. Song J, Li R, Jiang J. 2019


Subscribe to Search